Explore why clinicians are raising alarms about generic drug quality. New data links overseas manufacturing to higher adverse events, highlighting gaps in FDA inspections and supply chain transparency.
VIEW MOREThe FDA now conducts unannounced inspections of foreign generic drug factories to close a safety gap. Learn how CGMP standards, new inspection rules, and global supply chains affect the medicines you take every day.
VIEW MORE